{"name":"Axcella Health, Inc","slug":"axcella-health-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AXA1125","genericName":"AXA1125","slug":"axa1125","indication":"Non-alcoholic fatty liver disease (NAFLD)","status":"phase_2"}]}],"pipeline":[{"name":"AXA1125","genericName":"AXA1125","slug":"axa1125","phase":"phase_2","mechanism":"AXA1125 is a composition of amino acids and metabolites designed to restore metabolic balance and improve liver function in patients with metabolic dysfunction.","indications":["Non-alcoholic fatty liver disease (NAFLD)","Non-alcoholic steatohepatitis (NASH)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBVd0FwbXJNcjZIYURRZGdoNzdBUVZJaUV2cUNkRkhONlIwVERWX2ZTaWpYN19BakRxVXlNY3BwTTJtQlQzSFBFbGFRM2FqbDJhMnFGSHA3Z1pZT3ZrM0FvTTdIcFl6Z1RveUJSR3Z5U3MxOG5Tai1UN05zd9IBgwFBVV95cUxNLUNFNkJhanh5ejk3SkQzaHV4UlZXRlNPSmVzelAtM29SRlZuOUhjMmRCSEg0bFVrRElaTkliNjRxS2ppZXlqLWpkX3hWbVUzR0ZWbUNRQ3pTaHgyWl9HTzRMdmtCU2JSbC16RE5LSjRIRzFkYmVnMUptb1hmTmxNQkVfQQ?oc=5","date":"2024-04-12","type":"pipeline","source":"Delaware Business Times","summary":"Prelude Therapeutics finance officer departs - Delaware Business Times","headline":"Prelude Therapeutics finance officer departs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNWU5WNWVCRG1DRjFYWGZRZWFYaXppZFVBZnJtTEVnb1M2RG9WM29OV0laR2Rac2FjRmItYVBwWG5MczFKam84RGNZZXJlbVlEZnNJVThjd1M5NFB3amdBQkMyZGtzbUdJUlYxVmc3UnJobTV1R1d2dnFKNm9mSk1lRTROb1dNY1dPdnRmWW8wLWtYTE9u?oc=5","date":"2024-01-02","type":"pipeline","source":"The Business Journals","summary":"The definitive Boston biotech layoff tracker for 2023 - The Business Journals","headline":"The definitive Boston biotech layoff tracker for 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOdXR0NXhtVkNMMUNPTVM2WjB0YW1rMk9QSHk5Z1ZVR2hWNkxoZmRsV19mYmVlWXFlUHFIb2tYM2pOWWdwZU5Na0pvVXdGejZScHNUei16OWlUaGtlSVByTW9PM3czT1NjUm5ydVljbGdlTFZJbzR3YTJvOXFwSVE2TlNoN2xpTkNJXzU4MUZWbmkzMVdOLWtxRUhn?oc=5","date":"2023-12-08","type":"pipeline","source":"BioSpace","summary":"Axcella Health Becomes the Latest Flagship Company to Close its Doors - BioSpace","headline":"Axcella Health Becomes the Latest Flagship Company to Close its Doors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPenlJY21zT1N5VzBjeHdBc01KWXFWNlktVUpjdzRFRWlsY2F5TmYxOXJCY2lwa3luNXdVMDVOUHd1NTFFUUVBOVIxemRzZm5OTGtQMFdYVmY0dXY2RnJHTGxvVmZCQzhrS2dEblZXejBtcjZZdVhYQWhrcC1vcHEyMkFZc1JFeU92dUdoNnpTcUU3eE5JOGQ3b1RuY21nMXNXUlFPYzhqX0pRYjFKaEpYajN2QQ?oc=5","date":"2023-12-05","type":"pipeline","source":"Fierce Biotech","summary":"Axcella gets the ax: Flagship-founded biotech closes doors after 12-year run - Fierce Biotech","headline":"Axcella gets the ax: Flagship-founded biotech closes doors after 12-year run","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1lQzBHZllROXdvNktCRUhuRURvM3pTdnAyN1hNb1RTR3Q4WlR6SERBcHJDX3NfQWlRT2ZwbDlMX2ljX19ReTZERWlaZU04Wllxb0ZCTVdEbXNhX1FyaWZwbjQ1SQ?oc=5","date":"2023-09-18","type":"trial","source":"Wiley Online Library","summary":"Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitis - Wiley Online Library","headline":"Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed no","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNV2c2U1BPREdOUjBjeGhpcHUtWkxmdEZtSFBvRmhOQ0dVTEhvQ04xZjBVMDlCSE91ZkRVNlNoeGZMTFh0aDFsNC1WczFfTEZReVJNNm93eUkxNHdVQmFjZkJxd0RjTWwzcllqb1FqaDFsNVRoYXV2THpySDBoVGZsWWRQOGQxNFFNQTE2cUtHLXNSaEFiRWhncnZoMzVMNVVHVHB2OGFKQl9LQXBvaS1jSzllM0MtN0lFT1lfUmg0OUhaQQ?oc=5","date":"2023-08-29","type":"patent","source":"Proactive financial news","summary":"Axcella Health stock rockets on long Covid patent win - Proactive financial news","headline":"Axcella Health stock rockets on long Covid patent win","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPZ3ItVUF2TkhOa2JFdjhDclpXNkVUQ3B3RGk3T3RBVy1RQ1pzVENfejFRWGZlNm15ZmV3MVAtOUFneFpoT3F0QkZ3eVVGdk55Wl9ZQXpvcjVkeXhfUjNlYWxOdXBqdVJVMFR4dnYtOVlBR2syYVBtMlFIREtLbTNJNkxfc1A5TGJSbXEyS2w1QXp2ekJVaFJabEtXa2dwQ1ZQbGVDQ2FmckVMN19NVU45ZzZ3?oc=5","date":"2022-12-15","type":"trial","source":"Medical Marketing and Media","summary":"Axcella axes 85% of staff after long COVID drug fails in Phase II trials - Medical Marketing and Media","headline":"Axcella axes 85% of staff after long COVID drug fails in Phase II trials","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNby1HdVlrTW9UOGRiR0ZEVXFfLUtBT3pxS21NbnA4ZXRGd2l6a2doWDlYN0d6eVBncG9aZEdOVUI1ZG50dFdoN2haVXprMGJaTDg3WkU2S3FWZEVqdjEyY2NCN0w4SVRNUWZ2Q29fakVGZmk2M2lYZHBpRXI1dDlDaENmOFRNV28zemd1eUhKWjdjbzlacHFtb1lrTzMyRGFjbEZmZXJ6OUpZTmV2SnpUUDVUNUcwNlpqb0hGU0xSaU4wY0dGVmtqQURnZ2lqcGtQX2FEd0F3?oc=5","date":"2022-11-08","type":"pipeline","source":"Healio","summary":"Efruxifermin induces NASH resolution, improves fibrosis by at least 1 stage vs. placebo - Healio","headline":"Efruxifermin induces NASH resolution, improves fibrosis by at least 1 stage vs. placebo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNdGNLWDVzUEcxTXBCc3BVUlJBdXlUcE9GTW5vV1hBZFZQSkpzanVIVkxwYXZoNDNiOXpVRFNmdUZ2LWZZbW1SN1lCeE5aTVdxNjk5X0V6c1hhc2t2Y29MXzFiLWlKVDBYZ0o2SWQxdjNGMk1nenRfZG1KWVJ0SGtNeFAyQU0wZE1LZ0FlSWlUUUxMbGpMajI5a0RMQjJrSVMwbjhXVkhEUEFYS2FLZmYybzJpWDVLZjN4eU5sMjllbE5fd3ZTcU00SGJzZy0?oc=5","date":"2022-08-02","type":"trial","source":"reuters.com","summary":"Axcella long COVID treatment helps some patients in small trial - reuters.com","headline":"Axcella long COVID treatment helps some patients in small trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5YeHBXYmpZOGs0dUFsY3VHMGZzSVpXUVkweWtYbWVwdWZJbTBqd2ptOE50Ymh1bWVkbVJHUmRDUHNJR2RMQU52MDhtV3hDQU1nQ2JqMEtMcmFIb2RaZy1R?oc=5","date":"2021-05-12","type":"pipeline","source":"nature.com","summary":"People - nature.com","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNR251NTNjN0hLSkFOZk5fbjdyVjh3TmprbU8tOHZFS1ZLb0xtelJ4dGZ5amFIVUhxanhJY0k5VXFxdVREdFNMMm9uc25tcVY4bVUweFJEZTZfYnQxNjdBSks0Y21Vb0lZTEtHUHhhXzZOSXV2dG1TMHA5NmNBV0hSb1ZqZWtWd0NI?oc=5","date":"2018-07-02","type":"pipeline","source":"drugchannels.net","summary":"CBI’s 4th Annual Compliance Congress for Specialty Products - drugchannels.net","headline":"CBI’s 4th Annual Compliance Congress for Specialty Products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5sd3FnM1Y0Z2Z6bEJLR2ozZFItaTY0LUQ4ZEg2ZXFRSEpndmNqYzQ5UmNyUVVfSXYzTVF5MUFNbG93elJqLWFyMVBDTENSemlYY0pOdTdIaU9teEhrYl9jZUhMdWR3WFZNYXdYbHNVS1A?oc=5","date":"2018-06-06","type":"pipeline","source":"PharmaLive","summary":"People on the Move: Specialty Pharma - PharmaLive","headline":"People on the Move: Specialty Pharma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}